Advancing Equity in Oncology: Innovative Approaches and Robust Frameworks to Address Cancer Health Disparities

Abstract

The 2023 Summit on Cancer Health Disparities took place from April 28 through April 30, 2023. This manuscript summarizes three pivotal talks that underscored significant discussions on cancer inequities. Dr. Hiba Khan’s session, “Rising Tide of Biomarker Selected Studies – How Genomic Testing is Key to Unlocking Inequities in Oncology Clinical Trial Access,” delved into the vital role genomic testing plays in eliminating disparities within oncology clinical trials. The next session by Dr. Curtiland Deville, titled “Advanced Imaging and Stage Migration – How Findings More Diseases May Lead to More Opportunities,” explored how advanced imaging and disease stage migration can unearth further opportunities for equitable treatment access. Lastly, Dr. Samuel Washington’s presentation, “Applying a Social Determinant of Health Framework to Address Clinical Trial Inequities,” offered a thorough exploration into the use of social determinants of health as a strategy to rectify clinical trial inequities. Under the guidance of the session’s chair, Dr. Hala Borno, these presentations foster a nuanced understanding of cancer disparities, emphasizing the importance of innovative approaches and robust frameworks to bridge the gap in cancer care and research. This summary is an essential reference point for practitioners, policymakers, and stakeholders invested in overcoming the profound challenge of cancer disparities.